
Sign up to save your podcasts
Or


The guys discuss the potential consequences of Pfizer finally acquiring AstraZeneca. After that they dive into earnings, a new report highlighting Apple's global iPhone recovery, and a reader email on the state of the SaaS industry.
By The Motley Fool4.7
16041,604 ratings
The guys discuss the potential consequences of Pfizer finally acquiring AstraZeneca. After that they dive into earnings, a new report highlighting Apple's global iPhone recovery, and a reader email on the state of the SaaS industry.

3,230 Listeners

1,500 Listeners

806 Listeners

942 Listeners

531 Listeners

1,186 Listeners

2,189 Listeners

825 Listeners

1,431 Listeners

1,047 Listeners

9,717 Listeners

194 Listeners

829 Listeners

84 Listeners

589 Listeners

1,034 Listeners

50 Listeners